Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
28 participants
INTERVENTIONAL
2024-04-12
2025-09-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Improving Sympathetic Activity, Hot Flashes, and Sleep in Midlife Women Using Inspiratory Muscle Strength Training
NCT06743269
Inspiratory Muscle Strength Training and Incentive Spirometer on Postmenopausal Asthmatic Women
NCT04267666
Inspiratory Muscle Strength Training in Adults With Obesity
NCT05459636
Inspiratory Muscle Training Using the O2 Trainer
NCT07005622
Blood Flow Reserve: Effects After Training With Heavy Inspiratory Exercises
NCT05632614
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Inspiratory Muscle Training (IMT) group
The test protocol requires participants to inhale maximally (maximum inspiratory pressure, MIP) against 2mm diameter leak and sustain inhalation (sustained maximal inspiratory pressure, SMIP) until task failure. Participants will complete 3 SMIP maneuvers with each training session and use the best of the three for that day's training template (corresponding to about 80% SMIP for the IMT group) via the PrO2Fit software. Participants must match or exceed the SMIP template with each increasing level of the work-rest ratio. Work at each level consists of 6 breaths, 36 breaths total. If six breaths are completed, the next level starts. Rest intervals will progressively shorten as training continues from 40-seconds to 5-seconds. The session will be terminated if participants are unable to match at least 90% of the training template for two consecutive breaths or have completed all 36 breaths. Training will be done 4 times a week, and over 8-weeks.
PrO2 Fit (IMT Trainer)
The device is used four times a week over a period of 8 weeks.
Sham Inspiratory Muscle Training (Sham-IMT) group
Similar to the IMT group protocol, participants will be required to complete 3 SMIP maneuvers with each training session. Participants will use the best of the three for that day's training template (corresponding to about 30% SMIP for the Sham-IMT group) via the PrO2Fit software. Participants must match or exceed the SMIP template with each increasing level of the work-rest ratio. Work at each level consists of 6 breaths, 36 breaths total. If six breaths are completed, the next level starts. Rest intervals will progressively shorten as training continues from 40-seconds to 30-, 20-, 15-, 10-, and 5-seconds. The training session will be terminated if participants are unable to match at least 90% of the training template for two consecutive breaths or have completed all 36 breaths. Training will be done 4 times a week, and over 8-weeks.
PrO2 Fit (IMT Trainer)
The device is used four times a week over a period of 8 weeks.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
PrO2 Fit (IMT Trainer)
The device is used four times a week over a period of 8 weeks.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Aged 50-75 years (confirmed by birth date listed on participant's driver license at screening visit)
* English-speaking
* Body mass index between 25.0 to 39.9 kg/m2
* Able to ambulate without assistance
* Own or have access to a Bluetooth-capable phone or tablet (IOS version 12.0 or later or Android version 7.0 or later)
Exclusion Criteria
* Greater than stage II hypertension (i.e., \>159/99 mm Hg)
* Current tobacco use (self-report)
* Habitually exercise training ≥ 2 days per week (self-report)
* Significant orthopedic limitations or other contraindications to strenuous exercise
* Live or work \> 80 miles from Bloomington, Indiana
* Anticipated elective surgery during the study period.
* Surgery to the chest or abdomen in the last 6 months.
* Plan to move residence or travel out of the local area during the study period.
* History of heart attack or heart condition.
* Current use of prescription medications that affect heart rate or blood vessel dilation (e.g., systemic b-adrenergic blockers, calcium channel blockers, and hormone replacement therapy).
* Diagnosis of asthma or chronic pulmonary disease.
* Current respiratory infection.
* Diagnosis of an aneurysm in the chest, abdomen, or brain.
* Psychological or social characteristics that would interfere with their ability to fully participate in the study.
50 Years
75 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Indiana University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Stephen J. Carter, Ph.D.
Assistant Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Stephen J Carter, Ph.D
Role: PRINCIPAL_INVESTIGATOR
Indiana University, Bloomington
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Indiana University
Bloomington, Indiana, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
20387
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.